European ADHD in substance use disorders prevalence study.

European ADHD in substance use disorders prevalence study. - EASP study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33223

Enrollment

500

Registered

2010-01-12

Start date

2009-06-01

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

verslaving ADHD attention deficit disorder with hyperactivity

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: adults who are referred for treatment of addiction age 18-65 capable of informed consent

Exclusion criteria

Exclusion criteria: -inability to fill in the screening questionnaire (e.g. due to limited literacy) - inability to participate due to drug intoxication, serious psychiatric and/or somatic problems. Efforts should be made to include these patients at a later stage in their treatment.

Design outcomes

Primary

Measure	Time frame
* study centres: descriptive characteristics regarding organisation size, referral processes, diagnostic and treatment procedure, allowing a comparison between the centres and their patient populations * participants: demographic data and diagnostic data (SUD; ADHD; bipolar disorder; depression; borderline and antisocial disorder).	—

Secondary

Measure	Time frame
nvt	—

Countries

Netherlands

Outcome results